AAAAAA

   
Results: 1-20 |
Results: 20
CLINICAL-EVALUATION OF 2 DOSAGES AND SCHEDULES OF IFOSFAMIDE IN COMBINATION WITH CISPLATIN IN NEOADJUVANT CHEMOTHERAPY OF PATIENTS WITH ADVANCED (STAGE III-IV) HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PHASE-II RANDOMIZED STUDY
Authors: MANTOVANI G GHIANI M LAI P MACCIO A DESSI D SUCCU G MASSA D CURRELI L MULAS C ESU S PROTO E CADEDDU G TORE G
Citation: G. Mantovani et al., CLINICAL-EVALUATION OF 2 DOSAGES AND SCHEDULES OF IFOSFAMIDE IN COMBINATION WITH CISPLATIN IN NEOADJUVANT CHEMOTHERAPY OF PATIENTS WITH ADVANCED (STAGE III-IV) HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PHASE-II RANDOMIZED STUDY, Oncology Reports, 5(6), 1998, pp. 1499-1505
COMPARISON OF ORAL 5-HT3-RECEPTOR ANTAGONISTS AND LOW-DOSE ORAL METOCLOPRAMIDE PLUS IM DEXAMETHASONE FOR THE PREVENTION OF DELAYED EMESIS IN HEAD AND NECK-CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: MANTOVANI G MACCIO A CURRELI L LAMPIS B GHIANI M BIANCHI A CONTU P
Citation: G. Mantovani et al., COMPARISON OF ORAL 5-HT3-RECEPTOR ANTAGONISTS AND LOW-DOSE ORAL METOCLOPRAMIDE PLUS IM DEXAMETHASONE FOR THE PREVENTION OF DELAYED EMESIS IN HEAD AND NECK-CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Oncology Reports, 5(1), 1998, pp. 273-280
INTERIM RESULTS OF A DOSE-INTENSE PHASE-I COMBINATION CHEMOTHERAPY REGIMEN WITH CISPLATIN AND EPIRUBICIN INCLUDING MEDROXYPROGESTERONE ACETATE (MPA) AND RIL-2 IN PRIMARY LUNG-CANCER
Authors: MANTOVANI G MACCIO A LAI P MASSA E GHIANI M SANTONA MC MUDU C CURRELI L MANCA G VERSACE R PISANO M
Citation: G. Mantovani et al., INTERIM RESULTS OF A DOSE-INTENSE PHASE-I COMBINATION CHEMOTHERAPY REGIMEN WITH CISPLATIN AND EPIRUBICIN INCLUDING MEDROXYPROGESTERONE ACETATE (MPA) AND RIL-2 IN PRIMARY LUNG-CANCER, Annals of oncology, 9, 1998, pp. 492-492
PREVENTION OF ACUTE EMESIS IN CANCER-PATIENTS RECEIVING HIGH-DOSE CISPLATIN (HD-CDDP) - COMPARISON OF TRANSDERMAL FENTANYL (TTS-F) VS IV ONDANSETRON (OND), BOTH COMBINED WITH DEXAMETHASONE (D)
Authors: CURRELI L GHIANI M DESSI D MASSA D MULAS C SUCCU G MANTOVANI G
Citation: L. Curreli et al., PREVENTION OF ACUTE EMESIS IN CANCER-PATIENTS RECEIVING HIGH-DOSE CISPLATIN (HD-CDDP) - COMPARISON OF TRANSDERMAL FENTANYL (TTS-F) VS IV ONDANSETRON (OND), BOTH COMBINED WITH DEXAMETHASONE (D), Annals of oncology, 9, 1998, pp. 712-712
ANTIEMETIC EFFECT OF FENTANYL IN CISPLATIN-INDUCED ACUTE EMESIS (NAUSEA VOMITING)/
Authors: MANTOVANI G CURRELI L GHIANI M MACCIO A
Citation: G. Mantovani et al., ANTIEMETIC EFFECT OF FENTANYL IN CISPLATIN-INDUCED ACUTE EMESIS (NAUSEA VOMITING)/, Annals of oncology, 9, 1998, pp. 214-214
NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2
Authors: MANTOVANI G GEBBIA V AIROLDI M BUMMA C CONTU P BIANCHI A GHIANI M DESSI D MASSA E CURRELI L LAMPIS B LAI P MULAS C TESTA A PROTO E CADEDDU G TORE G
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 47(3), 1998, pp. 149-156
CLINICAL AND IMMUNOLOGICAL EVALUATION OF SCHIZOPHYLLAN (SPG) IN COMBINATION WITH STANDARD CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: MANTOVANI G BIANCHI A CURRELI L GHIANI M ASTARA G LAMPIS B SANTONA MC DESSI D ESU S LAI P MASSA E MACCIO A PROTO E
Citation: G. Mantovani et al., CLINICAL AND IMMUNOLOGICAL EVALUATION OF SCHIZOPHYLLAN (SPG) IN COMBINATION WITH STANDARD CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, International journal of oncology, 10(1), 1997, pp. 213-221
NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC) - A MULTICENTER PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN (CDDP)-FU WITH CDDP+5-FU PLUS RECOMBINANT INTERLEUKIN-2 (RIL 2) - PRELIMINARY-RESULTS(5)
Authors: MANTOVANI G AIROLDI M BIANCHI A GHIANI M SUCCU G MASSA D CURRELI L LAMPIS B LAI P CADEDDU G BUMMA C
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC) - A MULTICENTER PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN (CDDP)-FU WITH CDDP+5-FU PLUS RECOMBINANT INTERLEUKIN-2 (RIL 2) - PRELIMINARY-RESULTS(5), European journal of cancer, 33, 1997, pp. 57-57
GOLD RECOVERY ENHANCEMENT FROM COMPLEX SULFIDE ORES THROUGH COMBINED BIOLEACHING AND CYANIDATION
Authors: CURRELI L LOI G PERETTI R ROSSI G TROIS P ZUCCA A
Citation: L. Curreli et al., GOLD RECOVERY ENHANCEMENT FROM COMPLEX SULFIDE ORES THROUGH COMBINED BIOLEACHING AND CYANIDATION, Minerals engineering, 10(6), 1997, pp. 567-576
VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL AS INITIAL TREATMENT FOR PREVIOUSLY UNTREATED, UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESULTS OF A PHASE-II MULTICENTER STUDY
Authors: GEBBIA V MANTOVANI G FARRIS A AGOSTARA B DESOGUS A CURRELI L MOSCHELLA F DIGREGORIO C BAJETTA E GEBBIA N
Citation: V. Gebbia et al., VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL AS INITIAL TREATMENT FOR PREVIOUSLY UNTREATED, UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESULTS OF A PHASE-II MULTICENTER STUDY, Cancer, 79(7), 1997, pp. 1394-1400
IMPACT OF PSYCHOSOCIAL INTERVENTION ON THE QUALITY-OF-LIFE OF ELDERLYCANCER-PATIENTS
Authors: MANTOVANI G ASTARA G LAMPIS B BIANCHI A CURRELI L ORRU W CARPINIELLO B CARTA MG SORRENTINO M RUDAS N
Citation: G. Mantovani et al., IMPACT OF PSYCHOSOCIAL INTERVENTION ON THE QUALITY-OF-LIFE OF ELDERLYCANCER-PATIENTS, Psycho-oncology, 5(2), 1996, pp. 127-135
NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE
Authors: MANTOVANI G GEBBIA V PROTO E COSSU F BIANCHI A CURRELI L GHIANI M MASSA E ASTARA G LAMPIS B DESSI D SANTONA MC
Citation: G. Mantovani et al., NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(5), 1996, pp. 1035-1043
NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE
Authors: MANTOVANI G GEBBIA V PROTO E COSSU F BIANCHI A CURRELI L GHIANI M ASTARA G LAMPIS B DESSI D SANTONA MC MASSA E
Citation: G. Mantovani et al., NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(3), 1996, pp. 571-578
CHEMOIMMUNOTHERAPY FOR ADVANCED-STAGE MALIGNANCIES AND ITS IMPACT ON QUALITY-OF-LIFE - MULTIDIMENSIONAL EVALUATION IN 10 CANCER-PATIENTS
Authors: CURRELI L LAMPIS B SANTONA MC MANTOVANI G
Citation: L. Curreli et al., CHEMOIMMUNOTHERAPY FOR ADVANCED-STAGE MALIGNANCIES AND ITS IMPACT ON QUALITY-OF-LIFE - MULTIDIMENSIONAL EVALUATION IN 10 CANCER-PATIENTS, Supportive care in cancer, 4(6), 1996, pp. 462-464
EVALUATION BY MULTIDIMENSIONAL INSTRUMENTS OF HEALTH-RELATED QUALITY-OF-LIFE OF ELDERLY CANCER-PATIENTS UNDERGOING 3 DIFFERENT PSYCHOSOCIALTREATMENT APPROACHES - A RANDOMIZED CLINICAL-TRIAL
Authors: MANTOVANI G ASTARA G LAMPIS B BIANCHI A CURRELI L ORRU W CARTA MG CARPINIELLO B CONTU P RUDAS N
Citation: G. Mantovani et al., EVALUATION BY MULTIDIMENSIONAL INSTRUMENTS OF HEALTH-RELATED QUALITY-OF-LIFE OF ELDERLY CANCER-PATIENTS UNDERGOING 3 DIFFERENT PSYCHOSOCIALTREATMENT APPROACHES - A RANDOMIZED CLINICAL-TRIAL, Supportive care in cancer, 4(2), 1996, pp. 129-140
COMPARISON OF GRANISETRON, ONDANSETRON, AND TROPISETRON IN THE PROPHYLAXIS OF ACUTE NAUSEA AND VOMITING INDUCED BY CISPLATIN FOR THE TREATMENT OF HEAD AND NECK-CANCER - A RANDOMIZED CONTROLLED TRIAL
Authors: MANTOVANI G MACCIO A BIANCHI A CURRELI L GHIANI M PROTO E SANTONA MC
Citation: G. Mantovani et al., COMPARISON OF GRANISETRON, ONDANSETRON, AND TROPISETRON IN THE PROPHYLAXIS OF ACUTE NAUSEA AND VOMITING INDUCED BY CISPLATIN FOR THE TREATMENT OF HEAD AND NECK-CANCER - A RANDOMIZED CONTROLLED TRIAL, Cancer, 77(5), 1996, pp. 941-948
COMPARISON OF GRANISETRON VS ONDANSETRON VS TROPISETRON IN THE PROPHYLAXIS OF ACUTE NAUSEA AND VOMITING INDUCED BY HIGHLY EMETOGENIC CHEMOTHERAPY (HIGH-DOSE CISPLATIN) FOR TREATMENT OF PRIMARY HEAD AND NECK-CANCER - AN OPEN CROSS-OVER RANDOMIZED CONTROLLED TRIAL (RCT)
Authors: MANTOVANI G MACCIO A BIANCHI A CURRELI L GHIANI M SANTONA MC TESTA A GEBBIA V
Citation: G. Mantovani et al., COMPARISON OF GRANISETRON VS ONDANSETRON VS TROPISETRON IN THE PROPHYLAXIS OF ACUTE NAUSEA AND VOMITING INDUCED BY HIGHLY EMETOGENIC CHEMOTHERAPY (HIGH-DOSE CISPLATIN) FOR TREATMENT OF PRIMARY HEAD AND NECK-CANCER - AN OPEN CROSS-OVER RANDOMIZED CONTROLLED TRIAL (RCT), European journal of cancer, 31A, 1995, pp. 1206-1206
MEGESTROL-ACETATE IN NEOPLASTIC ANOREXIA CACHEXIA - CLINICAL-EVALUATION AND COMPARISON WITH CYTOKINE LEVELS IN PATIENTS WITH HEAD AND NECK-CARCINOMA TREATED WITH NEOADJUVANT CHEMOTHERAPY
Authors: MANTOVANI G MACCIO A BIANCHI A CURRELI L GHIANI M SANTONA MC DELGIACCO GS
Citation: G. Mantovani et al., MEGESTROL-ACETATE IN NEOPLASTIC ANOREXIA CACHEXIA - CLINICAL-EVALUATION AND COMPARISON WITH CYTOKINE LEVELS IN PATIENTS WITH HEAD AND NECK-CARCINOMA TREATED WITH NEOADJUVANT CHEMOTHERAPY, International journal of clinical & laboratory research, 25(3), 1995, pp. 135-141
TREATMENT OF RECURRENT AND OR METASTATIC SQUAMOUS-CELL HEAD AND NECK-CARCINOMA WITH A COMBINATION OF VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL - A MULTICENTER PHASE-II TRIAL/
Authors: GEBBIA V MANTOVANI G AGOSTARA B CONTU A FARRIS A COLUCCI G COGNETTI F RESTIVO G SPECIALE R FERRERO B TESTA A CURRELI L CARDINALE A BAJETTA E GEBBIA N
Citation: V. Gebbia et al., TREATMENT OF RECURRENT AND OR METASTATIC SQUAMOUS-CELL HEAD AND NECK-CARCINOMA WITH A COMBINATION OF VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL - A MULTICENTER PHASE-II TRIAL/, Annals of oncology, 6(10), 1995, pp. 987-991
NEOADJUVANT CHEMOTHERAPY+ -IMMUNOTHERAPY WITH SC-IL-2 IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PILOT-STUDY/
Authors: MANTOVANI G BIANCHI A CURRELI L GHIANI M
Citation: G. Mantovani et al., NEOADJUVANT CHEMOTHERAPY+ -IMMUNOTHERAPY WITH SC-IL-2 IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PILOT-STUDY/, Biotherapy, 8(2), 1995, pp. 91-98
Risultati: 1-20 |